Hu Q, Shi Y, Wang H, Bing L, Xu Z
Exp Hematol Oncol. 2025; 14(1):37.
PMID: 40087690
DOI: 10.1186/s40164-025-00627-6.
Zhu R, Huang J, Qian F
Front Immunol. 2025; 16:1556209.
PMID: 40079009
PMC: 11897577.
DOI: 10.3389/fimmu.2025.1556209.
Burns G, Fu Z, Vegter E, Madaj Z, Greaves E, Flores I
iScience. 2025; 28(2):111790.
PMID: 39935459
PMC: 11810701.
DOI: 10.1016/j.isci.2025.111790.
Dizibuyuk O, Bozdag Z, Karakok M
Diagnostics (Basel). 2025; 15(1.
PMID: 39795582
PMC: 11719943.
DOI: 10.3390/diagnostics15010053.
Nguyen O, Lara S, Ferro G, Peipp M, Kleinau S
Front Immunol. 2024; 15:1483617.
PMID: 39712032
PMC: 11659266.
DOI: 10.3389/fimmu.2024.1483617.
Anti-tumor and anti-metastatic effects of RRx-001 on hepatocellular carcinoma: mechanisms of action and therapeutic potential.
Yan G, Zhao S, Chen M, Mo S, Huang H, Liao Y
Front Pharmacol. 2024; 15:1469825.
PMID: 39664519
PMC: 11631591.
DOI: 10.3389/fphar.2024.1469825.
From acute lung injury to cerebral ischemia: a unified concept involving intercellular communication through extracellular vesicle-associated miRNAs released by macrophages/microglia.
Wang X, Wang T, Zhu D, Wang J, Han W
Clin Exp Immunol. 2024; 219(1).
PMID: 39658101
PMC: 11773807.
DOI: 10.1093/cei/uxae105.
INDUCTION OF EARLY PULMONARY SENESCENCE IN EXPERIMENTAL SEPSIS.
Mosenlechner M, Schlosser D, Braumuller S, Dorfer L, Mannes M, Kawach R
Shock. 2024; 63(3):448-455.
PMID: 39637172
PMC: 11882169.
DOI: 10.1097/SHK.0000000000002512.
CD47 and thrombospondin-1 contribute to immune evasion by .
Angabo S, Pandi K, David K, Steinmetz O, Makkawi H, Farhat M
Proc Natl Acad Sci U S A. 2024; 121(47):e2405534121.
PMID: 39536084
PMC: 11588058.
DOI: 10.1073/pnas.2405534121.
Role of gene expression in colorectal cancer: a comprehensive molecular profiling study.
Arai H, Gandhi N, Battaglin F, Wang J, Algaze S, Jayachandran P
J Immunother Cancer. 2024; 12(11.
PMID: 39500526
PMC: 11733795.
DOI: 10.1136/jitc-2024-010326.
The Physiological and Therapeutic Role of CD47 in Macrophage Function and Cancer.
Bess S, Igoe M, Muldoon T
Immunol Invest. 2024; 54(1):112-146.
PMID: 39415597
PMC: 11774679.
DOI: 10.1080/08820139.2024.2415409.
Mechanistic studies of tumor-associated macrophage immunotherapy.
Cao J, Liu C
Front Immunol. 2024; 15:1476565.
PMID: 39403370
PMC: 11472702.
DOI: 10.3389/fimmu.2024.1476565.
Beyond resorption: osteoclasts as drivers of bone formation.
Xiang Q, Li L, Ji W, Gawlitta D, Walboomers X, van den Beucken J
Cell Regen. 2024; 13(1):22.
PMID: 39392536
PMC: 11469995.
DOI: 10.1186/s13619-024-00205-x.
A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma.
Qin L, Li Y, Zeng R, He Y, Chen X, Xiao L
Hum Vaccin Immunother. 2024; 20(1):2408088.
PMID: 39348228
PMC: 11445887.
DOI: 10.1080/21645515.2024.2408088.
The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets.
Lorestani P, Dashti M, Nejati N, Habibi M, Askari M, Robat-Jazi B
Discov Oncol. 2024; 15(1):369.
PMID: 39186144
PMC: 11347554.
DOI: 10.1007/s12672-024-01256-x.
Deciphering the role of CD47 in cancer immunotherapy.
Liu Y, Weng L, Wang Y, Zhang J, Wu Q, Zhao P
J Adv Res. 2024; 63:129-158.
PMID: 39167629
PMC: 11380025.
DOI: 10.1016/j.jare.2023.10.009.
Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38.
Li S, Chen D, Yang Y, Guo H, Liu D, Sun N
Front Immunol. 2024; 15:1398508.
PMID: 38983860
PMC: 11231100.
DOI: 10.3389/fimmu.2024.1398508.
Promising immunotherapeutic approaches for primary effusion lymphoma.
Panaampon J, Okada S
Explor Target Antitumor Ther. 2024; 5(3):699-713.
PMID: 38966176
PMC: 11220309.
DOI: 10.37349/etat.2024.00242.
Clinicopathological analysis of immunohistochemical CD47 and signal-regulatory protein-α expression in Extranodal Natural killer/T-cell lymphoma.
Tan Z, Zhang Q, Wang Y, Wang Y, Zhang S, Xing X
Ann Hematol. 2024; 103(8):3033-3042.
PMID: 38886192
DOI: 10.1007/s00277-024-05852-3.
The biological roles of CD47 in ovarian cancer progression.
Xing L, Wang Z, Feng Y, Luo H, Dai G, Sang L
Cancer Immunol Immunother. 2024; 73(8):145.
PMID: 38832992
PMC: 11150368.
DOI: 10.1007/s00262-024-03708-3.